From: Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
Fatty acids | Odds ratio (95% confidence interval) | P value | ||||
---|---|---|---|---|---|---|
1st Quartile | 2nd Quartile | 3rd Quartile | 4th Quartile | 5th Quartile | ||
Reference | ||||||
C-14:0 | 1.00 | 1.5 (0.03–82.4) | 2.2 (0.2–35.6) | 3.0 (0.1–124.7) | 4.5 (0.2–167.1) | 0.46 |
C-16 : 0 | 1.00 | 2.5 (0.2–48.4) | 1.7 (0.1–37.0) | 1.7 (0.03–101.0) | 2.5 (0.2–48.4) | <0.01 |
C-18 : 0 | 1.00 | 3.0 (0.1–119.0) | 4.0 (0.2–176.9) | 3.0 (0.03–904.8) | 6.0 (0.1–1378) | 0.34 |
C-20 : 0 | 1.00 | 1.7 (0.1–26.2) | 1.3 (0.02–84.0) | 1.3 (0.1–31.2) | 1.3 (0.02–84.0) | 0.01 |
C-16 : 1 | 1.00 | 3.7 (0.2–101.2) | 3.3 (0.2–59.4) | 2.5 (0.04–196.7) | 5.0 (0.2–297.8) | <0.01 |
C-18 : 1 | 1.00 | 3.7 (0.2–143.1) | 3.0 (0.1–141.2) | 3.0 (0.03–904.8) | 4.0 (0.1–361.0) | 0.19 |
C-22 : 1 | 1.00 | 3.0 (0.1–119.0) | 4.0 (1.2–176.9) | 3.0 (0.03–904.8) | 4.3 (0.1–423.2) | 0.23 |
C-18 : 2 | 1.00 | 0.5 (0.02–8.8) | 0.6 (0.03–13.5) | 0.6 (0.01–50.0) | 0.6 (0.02–19.3) | <0.01 |
C-18 : 3 | 1.00 | 0.2 (0.005–3.7) | 0.2 (0.01–5.6) | 0.5 (0.01–25.4) | 0.2 (0.01–5.6) | 0.05 |
C-20 : 4 | 1.00 | 0.4 (0.01–10.4) | 0.4 (0.01–10.4) | 0.7 (0.02–19.3) | 0.8 (0.03–17.8) | <0.01 |
C-20 : 3 | 1.00 | 0.6 (0.03–9.4) | 0.3 (0.01–6.6) | 0.6 (0.01–29.6) | 0.2 (0.005–3.6) | 0.02 |
C-20 : 5 | 1.00 | 1.2 (0.02–62.1) | 1.2 (0.02–62.1) | 1.8 (0.1–25.9) | 1.2 (0.07–19.9) | 0.04 |
C-22 : 6 | 1.00 | 0.3 (0.01–4.9) | 0.8 (0.1–12.9) | 0.8 (0.02–41.6) | 0.8 (0.02–41.6) | 0.36 |